Webinar Recorded October 6, 2026                                  Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

The 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome is the first guideline written jointly by the heart, cardiology, diabetes, and kidney societies—and it cuts across nearly every silo a health plan is organized around. In this kickoff webinar for AMCP's Metabolic Health LINK, we'll unpack the changes with the greatest impact on managed care pharmacy, including staging, risk calculation, therapy selection by comorbidity, and where obesity medications now sit within benefit design. A payer panel will then work through the real-world coverage, clinical, and operational questions plans are facing as these frameworks take hold. Join us to connect with peers and help shape how managed care responds to the evolving management of metabolic health holistically.